Capsule Endoscopy Market By Accessory (Wireless Capsule, Workstation & Recorder), By Product (Small Bowel, Esophageal, Colon), By Application (OGIB, Crohn’s, Small Intestine Tumors) Is Expected To Reach 886.3 Million In 2022: Grand View Research, Inc

June 2015 | Report Format: Electronic (PDF)

Global capsule endoscopy market is expected to reach USD 886.3 million by 2022; according to a new study by Grand View Research, Inc. Increasing prevalence of colorectal cancer, GI diseases and growing demand for precise and accurate diagnostic tools are expected to drive the capsule endoscopy market over the forecast period. According to a report published by the World Cancer Research Institute, about 54.0% of colorectal cancer cases occurred in developed countries and the number is expected to grow exponentially over the decade. The introduction of technologically advanced features such as WiFi enabled small bowel capsules featuring longer battery life are further expected to drive the demand for capsule endoscopy devices. Presence of favorable government initiatives are expected to play an imperative role in determining market trends over the forecast period. For instance, initiatives such as the DCPC’s National Comprehensive Cancer Control Program (NCCCP) in the U.S. aimed at increasing patient awareness levels pertaining to colorectal cancer screening is expected to boost usage rates during the forecast period.

 To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/capsule-endoscopes-market

Further key findings from the study suggest:

  • Wireless capsules dominated the accessory market in 2014 and are also expected to register lucrative growth over the forecast period. Increasing usage rates of colon, small intestine and esophageal screening is expected to drive segment growth. In addition, presence of supportive reimbursement policies and the introduction of technologically advanced products are expected to serve this market as future growth opportunities.

  • Small bowel endoscopy capsule was the leading product segment of the market in 2014. These devices find wide applications in treating diseases such as suspected Crohn’s disease, inflammatory bowel disease, obscure GI tract bleeding and small bowel neoplastic lesions and this is expected to serve the segment as a high impact rendering driver. Increasing prevalence of target diseases is also expected to make significant contributions towards market growth.

  • Capsule endoscopy finds the largest application in OGIB (Obscure gastrointestinal bleeding) diagnosis owing to, increasing usage of wireless capsule endoscopes in vascular and inflammatory lesion diagnoses

  • North America was the largest regional capsule endoscopy market in 2014. The region’s market position is attributed to by factors such as presence of sophisticated healthcare infrastructure, supportive reimbursement policies and growing adoption rates of minimally invasive surgeries.

  • Asia Pacific region is anticipated to register rapid growth over the forecast period owing to, factors such as the presence of high unmet needs with respect to colorectal screening, rising disposable income and patient awareness levels and improving healthcare infrastructure

  • Key market players of the capsule endoscopy market include RF System lab, Olympus Corporation, Chongqing Jinshan Science & Technology (Group) Co., Given Imaging, Ltd., Fujifilm Holding Corporation, IntroMedic Co., Ltd and CapsoVision.

Grand View Research has segmented the global capsule endoscopy market on the basis of accessory, product, application and region:

Global Capsule Endoscopy Accessories Outlook (Revenue, USD Million, 2012 - 2022)

  • Wireless capsule

  • Workstation and receiver

Global Capsule Endoscopy Product Outlook (Revenue, USD Million, 2012 - 2022)

  • Small bowel

  • Esophageal

  • Colon

Global Capsule Endoscopy Application Outlook (Revenue, USD Million, 2012 - 2022)

  • OGIB

  • Crohn’s disease

  • Small Intestine tumor

  • Others (Celiac, NSAID reactions)

Capsule Endoscopy Regional Outlook (Revenue, USD Million, 2014 - 2022)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Mexico

    • Brazil

  • MEA

    • South Africa

Request Sample
Request for Customization

Choose License Type:

Single User - $3,450
Multi User - $6,450
Enterprise User - $8,450

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA